Phase 1 Study of MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer
The primary objective of this study is to evaluate the safety and feasibility of Magnetic
Resonance Image (MRI) guided focal prostate cancer laser thermal ablation in males, ages
40-80 with biopsy confirmed early clinical stage prostate cancer (T1c or T2a) with an
identifiable lesion on mutliparametric MRI, with a Prostate Specific Antigen (PSA) of <
15ng/ml, who have not yet undergone pelvic radiation or hormonal deprivation therapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society